Category: Clinical Breakthroughs
-
Minimally Invasive Surgery Leads to Worse Survival for Cervical Cancer Patients
Minimally invasive hysterectomy results in worse overall survival outcomes for cancer patients than traditional open surgery, according to a new study.
-
Steadying the Symptoms of Parkinson’s Disease
Northwestern Medicine clinicians are at the forefront in using an advanced surgical treatment called deep brain stimulation to improve quality of life for patients with Parkinson’s and other movement disorders.
-
Investigating Treatment for High-Risk Breast Cancer
A drug called bevacizumab added to adjuvant chemotherapy did not improve outcomes for patients with a form of high-risk breast cancer, according to a study published in the Journal of Clinical Oncology.
-
Drug Improves Survival in Metastatic Breast Cancer
A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
-
Quality of Life Holds Steady With Prostate Cancer Drug
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
-
Diabetes Drug Reduces Risk of Heart Attacks, Strokes From Air Pollution
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.
-
Drug Shows Promise for Progressive Multiple Sclerosis
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
-
Researchers Demonstrate First Example of a Bioresorbable Electronic Medicine
Scientists have developed the first example of a bioresorbable electronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves the healing of a damaged nerve.
-
Clinical Trial Improves Outcomes for Older Patients With Hodgkin Lymphoma
A novel chemotherapy regimen led to improved outcomes for older patients with Hodgkin lymphoma, similar to those of younger patients, according to a Northwestern Medicine clinical trial.
-
Reducing HIV Risk in Young Transgender Women
A behavioral program significantly reduced the sexual risk for HIV infection among young transgender women, according to a Northwestern Medicine clinical trial.
